Management of atrial fibrillation after cardiac surgery - Part II: Prevention and treatment

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 16, Issue 5, 2002, Pages 626-637

  Hill, Laureen L ^a   De Wet, Charl ^a   Hogue Jr , Charles W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Cardiac surgery; Postoperative complications; Prevention and treatment

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; ESMOLOL; MAGNESIUM SULFATE; METOPROLOL; NIFEDIPINE; PAROXYPROPIONE; PROCAINAMIDE; SOTALOL; VERAPAMIL;

ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; BRONCHOSPASM; CARDIOVASCULAR RISK; CARDIOVERSION; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; DRUG INDUCED DISEASE; ELECTROCARDIOGRAM; GASTROINTESTINAL DISEASE; GLAUCOMA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART SURGERY; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTHYROIDISM; LIVER TOXICITY; LUNG FIBROSIS; LUNG TOXICITY; PATIENT MONITORING; PHOTOSENSITIVITY; POLYNEUROPATHY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; TORSADE DES POINTES; URINE RETENTION; VASODILATATION; XEROSTOMIA;

EID: 0036793167     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2002.126931     Document Type: Article

References (103)

1. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL: Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 56:539-549, 1993
2. Mathew JP, Parks R, Savino JS, et al: Atrial fibrillation following coronary artery bypass graft surgery: Predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. JAMA 276:300-306, 1996
3. Aranki SF, Shaw DP, Adams DH, et al: Predictors of atrial fibrillation after coronary artery surgery: Current trends and impact on hospital resources. Circulation 94:390-397, 1996
4. Hill LL, Kattapuram M, Hogue CW Jr: Management of atrial fibrillation after cardiac surgery: Part I. Pathophysiology and risk factors. J Cardiothorac Vasc Anesth 16:483-494, 2002
5. Andrews TC, Reimold SC, Berlin JA, Antman EM: Prevention of supraventricular arrhythmias after coronary artery bypass surgery: A meta-analysis of randomized control trials. Circulation 84:I-236-I-244, 1991 (suppl I)
6. Kowey PR, Taylor JE, Rials SJ, Marinchak RA: Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am J Cardiol 69:963-965, 1992
7. Hannes W, Fasol R, Zajonc H, et al: Diltiazem provides antiischemic and anti-arrhythmic protection in patients undergoing coronary bypass grafting. Eur J Cardiothorac Surg 7:239-245, 1993
8. Seitelberger R, Hannes W, Gleichauf M, et al: Effects of diltiazem on perioperative ischemia, arrhythmias, and myocardial function in patients undergoing elective coronary bypass grafting. J Thorac Cardiovasc Surg 107:811-821, 1994
9. Podesser B, Schwarzacher S, Zwolfer W, et al: Combined perioperative infusion of nifedipine and metoprolol provides antiischemic and antiarrhythmic protection in patients undergoing elective aortocoronary bypass surgery. Thorac Cardiovasc Surg 41:173-179, 1993
10. Laub GW, Janeira L, Muralidharan S, et al: Prophylactic procainamide for prevention of atrial fibrillation after coronary artery bypass grafting: A prospective, double-blind, randomized, placebo-controlled pilot study. Crit Care Med 21:1474-1478, 1993
11. Gold MR, O'Gara PT, Buckley MJ, DeSanctis RW: Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery. Am J Cardiol 78:975-979, 1996
12. Merrick AF, Odom NJ, Keenan DJ, Grotte GJ: Comparison of propafenone to atenolol for the prophylaxis of postcardiotomy supraventricular tachyarrhythmias: A prospective trial. Eur J Cardiothorac Surg 9:146-149, 1995
13. Ali IM, Sanalla AA, Clark V: Beta-blocker effects on postoperative atrial fibrillation. Eur J Cardiothorac Surg 11:1154-1157, 1997
14. Janssen J, Loomans L, Harink J, et al: Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: A randomized open trial. Angiology 37:601-609, 1986
15. Suttorp MJ, Kingma JH, Tjon Joe Gin RM, et al: Efficacy and safety of low- and high-dose sotalol versus propranolol in the prevention of supraventricular tachyarrhythmias early after coronary artery bypass operations. J Thorac Cardiovasc Surg 100:921-926, 1990
16. Nystrom U, Edvardsson N, Berggren H, et al: Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thorac Cardiovasc Surg 41:34-37, 1993
17. Suttorp MJ, Kingma JH, Peels HO, et al: Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. Am J Cardiol 68:1163-1169, 1991
18. Weber UK, Osswald S, Huber M, et al: Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: Is there a need for preoperative risk stratification? A prospective placebo-controlled study using low-dose sotalol. Eur Heart J 19:794-800, 1998
19. Parikka H, Toivonen L, Heikkila L, et al: Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery. J Cardiovasc Pharmacol 31:67-73, 1998
20. Gomes JA, Ip J, Santoni-Rugiu F, et al: Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: A randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 34:334-339, 1999
21. Evrard P, Gonzalez M, Jamart J, et al: Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low-dose sotalol. Ann Thorac Surg 70:151-156, 2000
22. Hohnloser SH, Meinertz T, Dammbacher T, et al: Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: Results of a prospective, placebo-controlled study. Am Heart J 121:89-95, 1991
23. Butler J, Harriss DR, Sinclair M, Westaby S: Amiodarone prophylaxis for tachycardias after coronary artery surgery: A randomized, double-blind, placebo-controlled trial. Br Heart J 70:56-60, 1993
24. Daoud EG, Strickberger SA, Man KC, et al: Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 337:1785-1791, 1997
25. Guarnieri T, Nolan S, Gottlieb SO, et al: Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: The Amiodarone Reduction in Coronary Heart (ARCH) trial. J Am Coll Cardiol 34:343-347, 1999
26. Lee SH, Chang CM, Lu MJ, et al: Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 70:157-161, 2000
27. Dörge H, Schoendube FA, Schoberer M, et al: Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations. Ann Thorac Surg 69:1358-1362, 2000
28. Redle JD, Khurana S, Marzan R, et al: Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. Am Heart J 138:144-150, 1999
29. Dimopoulou I, Marathias K, Daganou M, et al: Low-dose amiodarone-related complications after cardiac operations. J Thorac Cardiovasc Surg 114:31-37, 1997
30. Reddy P, Richerson M, Freeman-Bosco L, et al: Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation in coronary artery bypass surgery. Am J Health Syst Pharm 56:2211-2217, 1999
31. Mason JW: Amiodarone. N Engl J Med 316:455-466, 1987
32. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med 321:406-412, 1989
33. Soyka LF, Wirtz C, Spangenberg RB: Clinical safety profile of sotalol in patients with arrhythmias. Am J Cardiol 65:74A-81A, 1990
34. Stanton MS, Prystowsky EN, Fineberg NS, et al: Arrhythmogenic effects of antiarrhythmic drugs: A study of 506 patients treated for ventricular tachycardia or fibrillation. J Am Coll Cardiol 14:209-215, 1989
35. Sager PT, Perlmutter RA, Rosenfeld LE, Batsford WP: Antiarrhythmic drug exacerbation of ventricular tachycardia inducibility during electrophysiologic study. Am Heart J 123:926-933, 1992
36. Fuster V, Ryden LE, Asinger RW, et al: ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 38:1231-1266, 2001
37. Daubert JC, Mabo P: Atrial pacing for the prevention of postoperative atrial fibrillation: How and where to pace? J Am Coll Cardiol 35:1423-1427, 2000
38. Gerstenfeld EP, Hill MR, French SN, et al: Evaluation of right atrial and biatrial temporary pacing for the prevention of atrial fibrillation after coronary artery bypass surgery. J Am Coll Cardiol 33:1981-1988, 1999
39. Greenberg MD, Katz NM, Iuliano S, et al: Atrial pacing for the prevention of atrial fibrillation after cardiovascular surgery. J Am Coll Cardiol 35:1416-1422, 2000
40. Fan K, Lee KL, Chiu CS, et al: Effects of biatrial pacing in prevention of postoperative atrial fibrillation after coronary artery bypass surgery. Circulation 102:755-760, 2000
41. Daoud EG, Dabir R, Archambeau M, et al: Randomized, doubleblind trial of simultaneous right and left atrial epicardial pacing for prevention of post-open heart surgery atrial fibrillation. Circulation 102:761-765, 2000
42. Blommaert D, Gonzalez M, Mucumbitsi J, et al: Effective prevention of atrial fibrillation by continuous atrial overdrive pacing after coronary artery bypass surgery. J Am Coll Cardiol 35:1411-1415, 2000
43. Chung MK, Augostini RS, Asher CR, et al: Ineffectiveness and potential proarrhythmia of atrial pacing for atrial fibrillation prevention after coronary artery bypass grafting. Ann Thorac Surg 69:1057-1063, 2000
44. Timmermans C, Rodriguez LM, Smeets JL, Wellens HJ: Immediate reinitiation of atrial fibrillation following internal atrial defibrillation. J Cardiovasc Electrophysiol 9:122-128, 1998
45. Cmolik BL, Oritz J, Ayers GM, et al: Successful atrial defibrillation with very-low-energy shocks by means of temporary epicardial wire electrodes. J Thorac Cardiovasc Surg 111:392-398, 1996
46. 2+ transport in the heart. Nature 346:841-844, 1990
47. England MR, Gordon G, Salem M, Chernow B: Magnesium administration and dysrhythmias after cardiac surgery: A placebo-controlled, double-blind, randomized trial. JAMA 268:2395-2402, 1992
48. Wesley RC Jr, Haines DE, Lerman BB, et al: Effect of intravenous magnesium sulfate on supraventricular tachycardia. Am J Cardiol 63:1129-1131, 1989
49. Zaman AG, Alamgir F, Richens T, et al: The role of signalaveraged P-wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery. Heart 77:527-531, 1997
50. Toraman F, Karabulut EH, Alhan HC, et al: Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 72:1256-1261, 2001
51. Watanabe Y, Dreifus LS: Electrophysiological effects of magnesium and its interactions with potassium. Cardiovasc Res 6:79-88, 1972
52. Hasegawa J, Matsumoto T, Takami T, et al: Suppression of catecholamine-induced abnormal pacemaker activities by magnesium ion in guinea pig cardiac muscle cells. Magnesium 8:94-99, 1989
53. Kalman JM, Munawar M, Howes LG, et al: Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg 60:1709-1715, 1995
54. de Leeuw PW, Falke HE, Kho TL, et al: Effects of beta-adrenergic blockade on diurnal variability of blood pressure and plasma noradrenaline levels. Acta Med Scand 202:389-392, 1977
55. 4 replacement. J Card Surg 11:421-427, 1996
56. Speziale G, Ruvolo G, Fattouch K, et al: Arrhythmia prophylaxis after coronary artery bypass grafting: Regimens of magnesium sulfate administration. Thorac Cardiovasc Surg 48:22-26, 2000
57. Fanning WJ, Thomas CS Jr, Roach A, et al: Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting. Ann Thorac Surg 52:529-533, 1991
58. Bert AA, Reinert SE, Singh AK: A beta-blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 15:204-209, 2001
59. Karmy-Jones R, Hamilton A, Dzavik V, et al: Magnesium sulfate prophylaxis after cardiac operations. Ann Thorac Surg 59:502-507, 1995
60. Parikka H, Toivonen L, Pellinen T, et al: The influence of intravenous magnesium sulphate on the occurrence of atrial fibrillation after coronary artery bypass operation. Eur Heart J 14:251-258, 1993
61. Wistbacka JO, Koistinen J, Karlqvist KE, et al: Magnesium substitution in elective coronary artery surgery: A double-blind clinical study. J Cardiothorac Vasc Anesth 9:140-146, 1995
62. Solomon AJ, Berger AK, Trivedi KK. et al: The combination of propranolol and magnesium does not prevent postoperative atrial fibrillation. Ann Thorac Surg 69:126-129, 2000
63. Hohnloser SH, Kuck KH: Atrial fibrillation-maintaining sinus rhythm versus ventricular rate control: The PIAF trial. Pharmacological Intervention in Atrial Fibrillation. J Cardiovasc Electrophysiol 9:S121-126, 1998
64. The Planning and Steering Committees of the AFFIRM study for the NHLBI AFFIRM investigators. Atrial fibrillation follow-up investigation of rhythm management-the AFFIRM study design. Am J Cardiol 79:1198-1202, 1997
65. Botto GL, Politi A, Bonini W. et al: External cardioversion of atrial fibrillation: Role of paddle position on technical efficacy and energy requirements. Heart 82:726-730, 1999
66. Mittal S, Ayati S, Stein KM, et al: Transthoracic cardioversion of atrial fibrillation: Comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 101:1282-1287, 2000
67. Rabbino MD, Likoff W, Dreifus LS: Complications and limitations of direct current countershock. JAMA 190:417-420, 1964
68. Mugge A, Kuhn H, Daniel WG: The role of transesophageal echocardiography in the detection of left atrial thrombi. Echocardiography 10:405-417, 1993
69. Brown J, Sadler DB: Left atrial thrombi in non-rheumatic atrial fibrillation: Assessment of prevalence by transesophageal echocardiography. Int J Card Imaging 9:65-72, 1993
70. Stoddard MF, Dawkins PR, Prince CR, Ammash NM: Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographic study. J Am Coll Cardiol 25:452-459, 1995
71. Aberg H: Atrial fibrillation: I. A study of atrial thrombosis and systemic embolism in a necropsy material. Acta Med Scand 185:373-379, 1969
72. Bjerkelund CJ, Orning OM: The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. Am J Cardiol 23:208-216, 1969
73. Arnold AZ, Mick MJ, Mazurek RP, et al: Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol 19:851-855, 1992
74. Petersen P, Boysen G, Godtfredsen J, et al: Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1:175-179, 1989
75. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. N Engl J Med 323:1505-1511, 1990
76. Klein AL, Murray RD, Grimm RA: Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation. J Am Coll Cardiol 37:691-704, 2001
77. Fatkin D, Kuchar DL, Thorburn CW, Feneley MP: Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: Evidence for "atrial stunning" as a mechanism of thromboembolic complications. J Am Coll Cardiol 23:307-316, 1994
78. The Stroke Prevention in Atrial Fibrillation Investigators: Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Ann Intern Med 116:1-5, 1992
79. Hogue CW Jr, Murphy SF, Schechtman KB, Davila-Roman VG: Risk factors for early or delayed stroke after cardiac surgery. Circulation 100:642-647, 1999
80. Weber MA, Hasford J, Taillens C, et al: Low-dose aspirin versus anticoagulants for prevention of coronary graft occlusion. Am J Cardiol 66:1464-1468, 1990
81. Malouf JF, Alam S, Gharzeddine W, Stefadouros MA: The role of anticoagulation in the development of pericardial effusion and late tamponade after cardiac surgery. Eur Heart J 14:1451-1457, 1993
82. Rawles JM: What is meant by a "controlled" ventricular rate in atrial fibrillation? Br Heart J 63:157-161, 1990
83. Galve E, Rius T, Ballester R, et al: Intravenous amiodarone in treatment of recent-onset atrial fibrillation: Results of a randomized, controlled study, J Am Coll Cardiol 27:1079-1082, 1996
84. , Hjelms E: Procainamide conversion of acute atrial fibrillation after open-heart surgery compared with digoxin treatment. Scand J Thorac Cardiovasc Surg 26:193-196, 1992
85. Gleva MJ, Hogue CW Jr: Anti-arrhythmic agents, in Evers AS, Maze M (eds): Anesthetic Pharmacology: Physiologic Principles and Clinical Practice. St Louis, MO, Harcourt Health Sciences (in press)
86. Connolly SJ: Evidence-based analysis of amiodarone efficacy and safety. Circulation 100:2025-2034, 1999
87. Roy D, Talajic M, Dorian P, et al: Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 342:913-920, 2000
88. Connolly SJ, Mulji AS, Hoffert DL, et al: Randomized placebocontrolled trial of propafenone for treatment of atrial tachyarrhythmias after cardiac surgery. J Am Coll Cardiol 10:1145-1148, 1987
89. Di Biasi P, Scrofani R, Paje A, et al: Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation. Eur J Cardiothorac Surg 9:587-591, 1995
90. Larbuisson R, Venneman I, Stiels B: The efficacy and safety of intravenous propafenone versus intravenous amiodarone in the conversion of atrial fibrillation or flutter after cardiac surgery. J Cardiothorac Vasc Anesth 10:229-234, 1996
91. Cochrane AD, Siddins M, Rosenfeldt FL, et al: A comparison of amiodarone and digoxin for treatment of supraventricular arrhythmias after cardiac surgery. Eur J Cardiothorac Surg 8:194-198, 1994
92. Costeas C, Kassotis J, Blitzer M, Reiffel JA: Rhythm management in atrial fibrillation-with a primary emphasis on pharmacological therapy: Part 2. Pacing Clin Electrophysiol 21:742-752, 1998
93. Campbell TJ, Gavaghan TP, Morgan JJ: Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass: Comparison with disopyramide and digoxin in a randomised trial. Br Heart 154:86-90, 1985
94. VanderLugt JT, Mattioni T, Denker S, et al: Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. Circulation 100:369-375, 1999
95. Lee KS, Gibson JK: Unique ionic mechanism of action of ibutilide on freshly isolated heart cells. Circulation 92:2755-2757, 1995
96. + current in guinea pig ventricular cells. J Pharmacol Exp Ther 262:99-108, 1992
97. Stambler BS, Wood MA, Ellenbogen KA, et al: Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Circulation 94:1613-1621, 1996
98. Murray KT: Ibutilide. Circulation 97:493-497, 1998
99. + current in cardiac myocytes by dofetilide. J Pharmacol Exp Ther 262:809-817, 1992
100. Singh S, Zoble RG, Yellen L, et al: Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: The symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation 102:2385-2390, 2000
101. Frost L, Mortensen PE, Tingleff J, et al: Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery. Dofetilide Post-CABG Study Group. Int J Cardiol 58:135-140, 1997
102. Torp-Pedersen C, Moller M, Bloch-Thomsen PE, et al: Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med 341:857-865, 1999
103. Chun SH, Sager PT, Stevenson WG, et al: Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol 76:47-50, 1995